메뉴 건너뛰기
Journal of Oral Pathology and Medicine
Volumn 36, Issue 7, 2007, Pages 444-446
The management of fistulizing oral Crohn's disease with infliximab
Author keywords

Crohn's disease; Fistula; Infliximab; Oral
Indexed keywords

AMOXICILLIN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; ERYTHROMYCIN; INFLIXIMAB; METHOTREXATE; METRONIDAZOLE; PENICILLIN V; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
EID: 34447128790     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00430.x     Document Type: Article
Times cited : (16)
References (8)
  • 1
    • 2942612457 scopus 로고    scopus 로고
    • Maintenance of remission in Crohn's disease: Current and emerging therapeutic options
    • Brookes MJ, Green JRB. Maintenance of remission in Crohn's disease: current and emerging therapeutic options. Drugs 2004 64 : 1069 89.
    • (2004) Drugs , vol.64 , pp. 1069-89
    • Brookes, M.J.1    Green, J.R.B.2
  • 2
    • 1942435955 scopus 로고    scopus 로고
    • Safety of tumour necrosis factor-α antagonists
    • Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-α antagonists. Drug Saf 2004 27 : 307 24.
    • (2004) Drug Saf , vol.27 , pp. 307-24
    • Khanna, D.1    McMahon, M.2    Furst, D.E.3
  • 3
    • 17644409728 scopus 로고    scopus 로고
    • Antitumour necrosis factor alpha antibody in the treatment of Behçet's syndrome
    • Nakamura S, Ohno S. Antitumour necrosis factor alpha antibody in the treatment of Behçet's syndrome. Int Ophthalmol Clin 2005 45 : 179 89.
    • (2005) Int Ophthalmol Clin , vol.45 , pp. 179-89
    • Nakamura, S.1    Ohno, S.2
  • 4
    • 0035009740 scopus 로고    scopus 로고
    • Infliximab for the treatment of orofacial Crohn's disease
    • Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease. Inflamm Bowel Dis 2001 7 : 38 42.
    • (2001) Inflamm Bowel Dis , vol.7 , pp. 38-42
    • Mahadevan, U.1    Sandborn, W.J.2
  • 5
    • 7044226437 scopus 로고    scopus 로고
    • An open-label study of the human anti-TNF monoclonal antibody adalimumab in patients with prior loss of response or intolerance to infliximab for Crohn's disease
    • Sandborn WJ, Hanauer S, Loftus EV Jr., et al. An open-label study of the human anti-TNF monoclonal antibody adalimumab in patients with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol 2004 99 : 1984 9.
    • (2004) Am J Gastroenterol , vol.99 , pp. 1984-9
    • Sandborn, W.J.1    Hanauer, S.2    Loftus Jr., E.V.3
  • 6
    • 13744255984 scopus 로고    scopus 로고
    • Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab
    • Papadakis KA, Shaye OA, Vasiliauskas EA, et al. Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab. Am J Gastroenterol 2005 100 : 75 9.
    • (2005) Am J Gastroenterol , vol.100 , pp. 75-9
    • Papadakis, K.A.1    Shaye, O.A.2    Vasiliauskas, E.A.3
  • 7
    • 0025915095 scopus 로고
    • Recurrent buccal space abscesses: A complication of Crohn's disease
    • Malins TJ, Ward-Booth RP. Recurrent buccal space abscesses: a complication of Crohn's disease. Oral Surg Oral Med Oral Pathol 1991 72 : 19 21.
    • (1991) Oral Surg Oral Med Oral Pathol , vol.72 , pp. 19-21
    • Malins, T.J.1    Ward-Booth, R.P.2
  • 8
    • 0345714870 scopus 로고    scopus 로고
    • Salivary duct fistula and recurrent buccal space infection: A complication of Crohn's disease
    • Mills C, Amin M, Manisali M. Salivary duct fistula and recurrent buccal space infection: a complication of Crohn's disease. J Oral Maxillofac Surg 2003 61 : 1485 7.
    • (2003) J Oral Maxillofac Surg , vol.61 , pp. 1485-7
    • Mills, C.1    Amin, M.2    Manisali, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.